Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Samia Arshad, Paul E. Kilgore, Zohra Chaudhry, et al.
International Journal of Infectious Diseases (2020) Vol. 97, pp. 396-403
Open Access | Times Cited: 556

Showing 1-25 of 556 citing articles:

Immunopathology of Hyperinflammation in COVID-19
Joshua Gustine, Dennis Jones
American Journal Of Pathology (2020) Vol. 191, Iss. 1, pp. 4-17
Open Access | Times Cited: 480
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19
Ning Rosenthal, Zhun Cao, Jake Gundrum, et al.
JAMA Network Open (2020) Vol. 3, Iss. 12, pp. e2029058-e2029058
Open Access | Times Cited: 444
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 19-27
Open Access | Times Cited: 295
Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis
Farha Musharrat Noor, Md. Momin Islam
Journal of Community Health (2020) Vol. 45, Iss. 6, pp. 1270-1282
Open Access | Times Cited: 293
Patients with COVID-19: in the dark-NETs of neutrophils
Maximilian Ackermann, Hans‐Joachim Anders, Rostyslav Bilyy, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 11, pp. 3125-3139
Open Access | Times Cited: 252
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 250
Azithromycin in the treatment of COVID-19: a review
Daniel Echeverría-Esnal, Clara Martín‐Ontiyuelo, María Eugenia Navarrete-Rouco, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 2, pp. 147-163
Open Access | Times Cited: 233
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
Mentor Ali Ber Lucien, Michael F. Canarie, Paul E. Kilgore, et al.
International Journal of Infectious Diseases (2021) Vol. 104, pp. 250-254
Open Access | Times Cited: 223
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis
Giovanni Corona, Alessandro Pizzocaro, Walter Vena, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 275-296
Open Access | Times Cited: 210
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh, Hannah Ryan, Tamara Kredo, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 190
One year update on the COVID-19 pandemic: Where are we now?
Sanjay Kumar Mishra, Timir Tripathi
Acta Tropica (2020) Vol. 214, pp. 105778-105778
Open Access | Times Cited: 186
Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets
Zoya Serebrovska, Elisa Chong, Tatiana V. Serebrovskaya, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 12, pp. 1539-1546
Open Access | Times Cited: 185
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
Kathleen Chiotos, Molly Hayes, David W. Kimberlin, et al.
Journal of the Pediatric Infectious Diseases Society (2020) Vol. 9, Iss. 6, pp. 701-715
Open Access | Times Cited: 183
Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
Miguel Alejandro Pinzón, Santiago Ortiz, Héctor Holguín, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0252057-e0252057
Open Access | Times Cited: 178
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
Chris R. Triggle, Devendra Bansal, Hong Ding, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 165
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Yahya Mahamat‐Saleh, Thibault Fiolet, Mathieu E. Rebeaud, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e052777-e052777
Open Access | Times Cited: 164
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
Peter A. McCullough, Ronan J. Kelly, Gaetano Ruocco, et al.
The American Journal of Medicine (2020) Vol. 134, Iss. 1, pp. 16-22
Open Access | Times Cited: 162
Natural history of COVID-19 and therapeutic options
Philippe Gautret, Matthieu Million, Pierre‐André Jarrot, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 12, pp. 1159-1184
Closed Access | Times Cited: 143
Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
Eleni Karakike, Evangelos J. Giamarellos‐Bourboulis, Miltiades Kyprianou, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 12, pp. 2042-2057
Open Access | Times Cited: 140
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 120
SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress
Ryan Chang, Abrar Mamun, Abishai Dominic, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 114
Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease
Paul Terry, R. Eric Heidel, Rajiv Dhand
American Journal of Respiratory and Critical Care Medicine (2021) Vol. 203, Iss. 7, pp. 893-905
Open Access | Times Cited: 107
Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression
Santenna Chenchula, Kota Vidyasagar, Saman Pathan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate
Alexiane Pradelle, Sabine Mainbourg, Steeve Provencher, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116055-116055
Open Access | Times Cited: 24
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis
Zakariya Kashour, Muhammad Riaz, Musa A. Garbati, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 1, pp. 30-42
Open Access | Times Cited: 125
Page 1 - Next Page

Scroll to top